RECTOSIGMOID CANCER METASTATIC

RECTOSIGMOID CANCER METASTATIC was reported 37 times

RECTOSIGMOID CANCER METASTATIC is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 FRUQUINTINIB 5 0.0013
1 ZIV-AFLIBERCEPT 1 0.0008
2 PANITUMUMAB 9 0.0006
3 MIRVETUXIMAB SORAVTANSINE 1 0.0006
4 GLYCERIN SUPPOSITORY 1 0.0004
5 GLYCERIN SUPPOSITORIES 1 0.0004
6 DALTEPARIN SODIUM 3 0.0003
7 BEVACIZUMAB-AWWB 1 0.0002
8 REGORAFENIB 2 0.0002
9 LAMIVUDINE 4 0.0002
10 RAMUCIRUMAB 1 0.0002
11 SENNOSIDES 8.6 MG TABLETS 3 0.0001
12 SENNA LEAF 3 0.0001
13 OXALIPLATIN 9 0.0001
14 TENOFOVIR DISOPROXIL FUMARATE TABLETS 1 0.0001
15 FILGRASTIM 4 0.0001
16 SENNOSIDES 3 0.0001
17 FEBUXOSTAT TABLETS 40 MG 1 0.0001
18 TRIFLURIDINE AND TIPIRACIL 1 0.0001
19 FLUOROURACIL CREAM, 0.5% 7 0.0001
20 FLUOROURACIL 7 0.0001
21 LACTULOSE 3 0.0001
22 IRINOTECAN HYDROCHLORIDE 1 0.0001
23 FOSAPREPITANT DIMEGLUMINE 1 0.0001
24 ROMIPLOSTIM 1 0.0001
25 BEVACIZUMAB 8 0.0001
26 FEBUXOSTAT 1 0.0001
27 URSOSIOL 1 0.0001
28 URSODIOL 1 0.0000
29 CAPECITABINE 4 0.0000
30 FLUCONAZOLE 3 0.0000
31 ENALAPRIL MALEATE 1 0.0000
32 CETUXIMAB 1 0.0000
33 POMALIDOMIDE 3 0.0000
34 SPIRONOLACTONE 4 0.0000
35 USTEKINUMAB 2 0.0000
36 ALLOPURINOL 3 0.0000
37 DEXAMETHASONE 1.5 MG 5 0.0000
38 DEXAMETHASONE 5 0.0000
39 DAPAGLIFLOZIN 1 0.0000
40 METOPROLOL TARTRATE 4 0.0000
41 DABIGATRAN ETEXILATE MESYLATE 1 0.0000
42 DABIGATRAN ETEXILATE 1 0.0000
43 UPADACITINIB 1 0.0000
44 FINGOLIMOD HCL 1 0.0000
45 VEDOLIZUMAB 1 0.0000
46 HYDROXYCHLOROQUINE SULFATE 1 0.0000
47 FUROSEMIDE 4 0.0000
48 LENALIDOMIDE 4 0.0000
49 INFLIXIMAB 2 0.0000
50 CYCLOSPORINE 1 0.0000
51 ACYCLOVIR 1 0.0000
52 ONDANSETRON HYDROCHLORIDE 1 0.0000
53 CARVEDILOL 1 0.0000
54 PREDNISOLONE ORAL SOLUTION 1 0.0000
55 ESOMEPRAZOLE MAGNESIUM 1 0.0000
56 ASPIRIN 1 0.0000